Pay in 4 interest-free payments of $7.12 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Anti-neuroinflammatory potential of natural products in the treatment of Alzheimers disease
Semaglutide emerged from Novo Nordisks systematic GLP-1 analogue optimisation programme as the successor to liraglutide , incorporating structural modifications addressing the three principal pharmacokinetic vulnerabilities of native GLP-1: DPP-IV susceptibility at position 8 addressed by Aib8 alpha-aminoisobutyric acid substitution, proteolytic cleavage at position 34 addressed by Arg34Lys substitution, and the short half-life of unmodified GLP-1 analogues addressed by the C18 fatty diacid conjugation providing tighter albumin binding and longer half-life than liraglutides C16 fatty acid, producing the approximately one-week half-life enabling once-weekly subcutaneous administration
HIV-1 Tat targets Tip60 to impair the apoptotic cell response to genotoxic stresses
Once reconstituted, material should be held at 4 degrees Celsius for short-term use or below minus 18 degrees Celsius for longer-term storage, protected from light
